Natco Pharma Ltd today said it has commenced commercial production at its Dehradun unit.
The company informed the Bombay Stock Exchange that the finished dosage pharmacuetical formulations unit would achieve a capacity level of 300 million tablets per annum and the project is being implemented in stages.
AdvertisementPlans of establishing a parenterals division at Dehradun are also underway, it added.
The share of the company was trading at Rs 102.35, down 4.48 per cent on the BSE.
PAustralian Surgeons Successfully Conduct Worlds First Triple Organ Transplant Another Senior Doctor From AIIMS Contemplates Leaving Due to Infighting M
You May Also Like